Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002492 · ClinicalTrials.gov registry record · Phase 2
Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma
A Phase 2 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00002492: Completed Phase 2 study, sponsored by University of Miami.
NCT00002492 is a Phase 2 study that has completed, run by University of Miami. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002492, a Phase 2 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining cisplatin and doxorubicin in treating patients who have soft tissue sarcoma.
Interventions
- DRUG cisplatin
- PROCEDURE conventional surgery
- RADIATION brachytherapy
- DRUG doxorubicin hydrochloride
- DRUG isolated limb perfusion
Trial Details
| Field | Value |
|---|---|
| Start Date | 1991-11 |
| Est. Completion | 2000-02 |
| Phase | Phase 2 |
What the finished NCT00002492 record still lists
NCT00002492 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 5 interventions - of which cisplatin is the first listed.
NCT00002492 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002492 about?
NCT00002492 is a clinical study titled "Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining cisplatin and doxorubicin in treating patients who have sof...
What is the current status of trial NCT00002492?
This trial is currently completed. It is a Phase 2 study. The study started on 1991-11. Estimated completion is 2000-02.
What interventions are being tested in trial NCT00002492?
The interventions under investigation include: cisplatin (DRUG), conventional surgery (PROCEDURE), brachytherapy (RADIATION), doxorubicin hydrochloride (DRUG), isolated limb perfusion (DRUG).
Who is sponsoring clinical trial NCT00002492?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia